Publications by authors named "Steven Gilbert"

Claim this Profile
E
Efficacy and Safety of Zimlovisertib, Ritlecitinib, and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate.
Spencer I Danto, Mikhail Salganik, Anindita Banerjee, Pawel Hrycaj, Irina Jashi, Steven A Gilbert

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying Aggregate Statistical Analyses to Safety Monitoring of Ongoing Clinical Studies, Issues, and Opportunities in a Test Case.
Ed Whalen, Steven Gilbert, James Buchanan

Ther Innov Regul Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive data.
Chianna Umamahesan, Aleksandra Pilcicka, Jennifer Yick, Kieran Baker, Melvyn Smith, Steven Gilbert

Biochem J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha-2-Delta Ligand PD-217,014 in Patients With Irritable Bowel Syndrome.
Lesley A Houghton, Simiao Gao, Steven A Gilbert, Benoit Coffin, Magnus Simren

Aliment Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and testing Advance Choice Document implementation resources for Black African and Caribbean people with experience of compulsory psychiatric admission.
Jonathan Simpson, Abigail Babatunde, Alan Simpson, Steven Gilbert, Alex Ruck Keene

BMC Psychiatry· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis.
Spencer I Danto, Nikolaos Tsamandouras, Padma Reddy, Steven A Gilbert, Jessica Y Mancuso

Allergy Asthma Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis: A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study.
Spencer I Danto, Nikolaos Tsamandouras, Padmalatha Reddy, Steven Gilbert, Jessica Mancuso

J Clin Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality Tolerance Limits: A General Guidance for Parameter Selection and Threshold Setting.
Annett Keller, Nathalie van Borrendam, Patrice Benner, Steven Gilbert, Stefano Saino

Ther Innov Regul Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CITIES: Clinical trials with intercurrent events simulator.
Ahmad Hakeem Abdul Wahab, Yongming Qu, Hege Michiels, Junxiang Luo, Run Zhuang, Steven Gilbert

Biom J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional epigenetics education improves diet and attitude of parents of children with autism or attention deficit/hyperactivity disorder.
Renee J Dufault, Katherine M Adler, David O Carpenter, Steven G Gilbert, Raquel A Crider

World J Psychiatry· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advance Statements for Black African and Caribbean people (AdStAC): protocol for an implementation study.
Abigail Babatunde, Alex Ruck Keene, Alan Simpson, Steven Gilbert, Lucy Stephenson

BMC Psychiatry· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Treatment Responses in Patients With Osteoarthritis: Results From Two Phase III Tanezumab Randomized Clinical Trials.
Luana Colloca, Robert H Dworkin, John T Farrar, Leslie Tive, Jiyue Yang, Steven A Gilbert

Clin Pharmacol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher rates of autism and attention deficit/hyperactivity disorder in American children: Are food quality issues impacting epigenetic inheritance?
Renee J Dufault, Raquel A Crider, Richard C Deth, Roseanne Schnoll, Steven G Gilbert

World J Clin Pediatr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Diversity among Strains and Closely Related Species.
Sadaf Rasheed Mughal, Sadia Ambreen Niazi, Thuy Do, Steven C Gilbert, Xavier Didelot

Microorganisms· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of physical activity programs and services for older adults: a rapid review.
Marina B Pinheiro, Juliana S Oliveira, Jennifer N Baldwin, Leanne Hassett, Nathalia Costa, Steven Gilbert

Int J Behav Nutr Phys Act· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Yin yang': a pseudoaneurysm following a liver biopsy.
Serena Tieger, Steven Gilbert, Rebecca Creamer, Mansoor Zafar, Mark Whitehead

Br J Hosp Med (Lond)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial.
Aaron Winkler, Weiyong Sun, Saurav De, Aiping Jiao, M Nusrat Sharif, Steven A Gilbert

Arthritis Rheumatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical Benchmarks for Quality Tolerance Limits Parameters in Clinical Trials.
Marcin Makowski, Ruma Bhagat, Soazig Chevalier, Steven A Gilbert, Dagmar R Görtz

Ther Innov Regul Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connecting inorganic mercury and lead measurements in blood to dietary sources of exposure that may impact child development.
Renee J Dufault, Mesay M Wolle, H M Skip Kingston, Steven G Gilbert, Joseph A Murray

World J Methodol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial.
Seth B Forman, David M Pariser, Yves Poulin, Michael S Vincent, Steven A Gilbert

J Invest Dermatol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects.
Spencer I Danto, Negin Shojaee, Ravi Shankar P Singh, Cheryl Li, Steven A Gilbert

Arthritis Res Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing occupational lead exposures: Strengthened standards for a healthy workforce.
Rachel M Shaffer, Steven G Gilbert

Neurotoxicology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy.
Jeremy D Gale, Steven Gilbert, Samuel Blumenthal, Tom Elliott, Pablo E Pergola

Kidney Int Rep· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.
Jeremy D Gale, Brian Berger, Steven Gilbert, Serghei Popa, Marla B Sultan

Invest Ophthalmol Vis Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children.
Renee Dufault, Roseanne Schnoll, Walter J Lukiw, Blaise LeBlanc, Charles Cornett, Steven G Gilbert

Behav Brain Funct· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis